CN104558624A - Preparation and usage of novel dendrimer - Google Patents
Preparation and usage of novel dendrimer Download PDFInfo
- Publication number
- CN104558624A CN104558624A CN201310481091.0A CN201310481091A CN104558624A CN 104558624 A CN104558624 A CN 104558624A CN 201310481091 A CN201310481091 A CN 201310481091A CN 104558624 A CN104558624 A CN 104558624A
- Authority
- CN
- China
- Prior art keywords
- compound
- water
- soluble
- dendritic macromole
- dendrimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses preparation and usage of a novel dendrimer compound. The dendrimer is a dendrimer compound by taking the structure of a compound with the solubility less than 10 g in water as the core. The invention discloses the preparation method and usage of the novel dendrimer compound. The dendrimer compound, by taking the structure of the compound which is unlikely to dissolve in water as the core, can facilitate non-in vitro fertilization to take place in a human or animal body, that is, the novel dendrimer compound can adjust and control offspring gender fertility capacity during the normal fertility process.
Description
Technical field
The invention discloses a kind of preparation and purposes of dendrimer compound of novelty, the dendrimer that this dendritic macromole is is core with compound structure not soluble in water, the invention discloses Preparation Method And The Use.The dendrimer that should be core with compound structure not soluble in water can regulate and control the ability of fertility sex of children in the non-external fertilization of human or animal and normal reproduction process.
Background technology
At present, a kind of suitable effective method is not yet had directly can to screen follow-on sex in the coitus in the mammalian body of viviparity.Sharply expand and be manyly on the verge of the problem of species of disappearing facing population, scientists wishes to regulate and control sex, but external fertilization regulation and control sex, observe under being dependent only on high power microscope at present form, XY sperm dyeing or pass through electrophoresis, the instruments such as flow cytometer or technological means are separated XY sperm, not only injured sperm, and operate lengthy and tedious in operating process, cannot efficiently and take time and effort, success rate is low.The present inventor has invented a kind of brand-new dendrimer compound, sperm can be made to be screened, and namely this dendrimer can make human or animal in non-external fertilization and normal reproduction process, regulate and control the ability of fertility sex of children in vivo injury-freely.
This dendrimer compound that is core with compound structure not soluble in water prepared by the present invention farthest can stop the combination of X sperm and ovum after mammal sexual intercourse, indirectly impel y sperm to be combined with ovum, there is other ability of control in the natural growing process in Mammalian Reproduction field.Can limit the compound that X sperm is combined with ovum, this compound is safe and efficient, embodies positive effect in zoopery, not only effectively controls the natality of jenny, also effectively improves the natality of buck.What the compound of this invention can make normal reproduction filial generation malely heightens to 20:1 for 1:1 than female.
Summary of the invention
The invention discloses the structure shown in following formula, be a kind of be the new dendritic macromole of core containing compound structure, its feature be compound not soluble in water in the core of dendritic macromole, periphery is symmetrical dendritic macromole, and its structure is as follows:
Division center part wherein in this new dendrimer compound is compound not soluble in water, described Compound I nsoluble not soluble in water represents dissolubility in a kind of water and is less than the compound of 10g, namely compound not soluble in water, containing being slightly soluble in water or being insoluble in the compound of water.Wherein structure
Representative take S-S as kernel, and the m of the height cladodification of approximate sphericity is for dendritic macromole, and wherein m is the algebraically of dendritic macromole, and m gets the multiple of integer between 0-50 and 0.5.
And structure
All represent half dendritic macromole.Linker wherein in structure represents a kind of branch structure compound with three Ge Zhicha branches, a branch is connected with compound chemistry not soluble in water, another two branches and dendritic macromole chemistry is connected, the compound that to be formed with the compound not soluble in water periphery that is core be dendritic macromole.This branched compound contains the active group that can react with-SH.This branched compound, preferably
，
。
The preparation method of compound of the present invention, is characterized in that:
1) will be with S-S the dendritic macromole G of core
m, wherein m is the algebraically of dendritic macromole, and m gets the multiple of integer between 0-50 and 0.5, G
mbe decomposed under the catalysis of vitamin C, dithiothreitol, DTT or sodium sulfite and be good for half active dendritic macromole G with SH
ma;
2) branched compound L inker and Compound I nsoluble(dissolubility not soluble in water are less than 10g) coupling generates compd B with branched structure;
3) compd A stirred overnight in the solvent of 0-20 degree of the compd B of a times mole and twice mole is reacted, and is obtained by reacting the dendrimer C containing compound structure not soluble in water;
4) will prepare the rear lyophilizing of dendrimer C washing being core with compound structure not soluble in water of gained, or add freeze drying protectant, in vacuum drying oven, lyophilizing 24-96 hour, obtains final products for subsequent use;
React described structure as follows
Dendrimer compound Gm:
；
Compd A:
；
Compd B:
Wherein this structure
Belong to the structure in Linker structure;
Compound C:
Wherein said chemical step 1-4 selects solvent to be selected from: methyl ether, ether, petroleum ether, benzene, toluene, pyridine, oxolane, trifluoroacetic acid, chloroform, carbon tetrachloride, 3-(2-pyridine dimercapto) propanoic acid N-hydroxy-succinamide ester, tricresyl phosphate (2-chloroethyl) ester, dichloromethane, methanol, ethanol, dichloromethane, dimethyl sulfoxide, N, one or more in dinethylformamide, N, N'-dicyclohexylcarbodiimide.The purposes of compound of the present invention is the ability of regulation and control fertility sex of children in the non-external fertilization and normal reproduction process of human or animal.It is more male and less female that concrete finger can make human or animal give birth to after normal fertilization, normal reproduction filial generation male than female be 1:1, be 20:1 after using this compound.
Preparation method of the present invention is specific as follows:
1) will be with S-S the dendritic macromole G of core
m(commercially available), wherein m is the algebraically of dendritic macromole, and m gets the multiple of integer between 0-50 and 0.5, G
munder the catalysis of vitamin C (commercially available), dithiothreitol, DTT (commercially available) or sodium sulfite (commercially available), in organic solution, reduction decomposition is be good for half active dendritic macromole G with SH
ma;
2) branched compound L inker(is commercially available, also can prepare) be less than 10g with Compound I nsoluble(dissolubility not soluble in water) (commercially available) under PH is the condition of 5-9, reaction coupling in normal-temperature reaction 1-48 hour generates the compd B with branched structure, and then lyophilizing is for subsequent use;
3) compd A of the compd B of a times mole and twice mole spends the night low speed 50rpm-500rpm stirring reaction in the solvent of 0-20 degree, is obtained by reacting the dendrimer C containing compound structure not soluble in water;
4) be core with compound structure not soluble in water dendrimer C directly washs rear lyophilizing by what prepare gained, or add freeze drying protectant (potassium sorbate, mannitol, sodium carboxymethyl cellulose etc.), in vacuum drying oven, lyophilizing 24-96 hour, obtains final products for subsequent use;
Gm is reduced to and is good for half active dendritic macromole G with SH
ma
Insoluble+Linker generates B
B and half dendritic macromole reaction generate C:
+
For subsequent use after Compound C lyophilizing, for animal regulation and control sex after weigh.The dendrimer that is core with compound not soluble in water (i.e. dissolubility below 10 grams) structure of the present invention farthest can stop the combination of X sperm and ovum after human or animal's sexual intercourse, indirectly impel y sperm to be combined with ovum, there is other ability of control in the natural growing process in human or animal's field of reproduction.Due to the speciality of compound of the present invention itself, therefore also can be used for some medicines adjuvant application or the carrier as gene apply, especially the feature of its simultaneously conjugation chemistry medicine portability gene again, certainly will will make its control other simultaneously, can be used as again outstanding gene and chemicals carrier.
At present, a kind of suitable effective method is not yet had directly can to screen follow-on sex in the coitus in the mammalian body of viviparity.Sharply expand and be manyly on the verge of the problem of species of disappearing facing population, scientists wishes to regulate and control sex, but external fertilization regulation and control sex, observe under being dependent only on high power microscope at present form, XY sperm dyeing or pass through electrophoresis, the instruments such as flow cytometer or technological means are separated XY sperm, not only injured sperm, and operate lengthy and tedious in operating process, cannot efficiently and take time and effort, success rate is low.The present inventor has invented a kind of brand-new dendrimer compound, sperm can be made to be screened, and namely this dendrimer can make human or animal in non-external fertilization and normal reproduction process, regulate and control the ability of fertility sex of children in vivo injury-freely.
This dendrimer that is core with compound structure not soluble in water prepared by the present invention farthest can stop the combination of X sperm and ovum after mammal sexual intercourse, indirectly impel y sperm to be combined with ovum, there is other ability of control in the natural growing process in Mammalian Reproduction field.Can limit the compound that X sperm is combined with ovum, this compound is safe and efficient, embodies positive effect in zoopery, not only effectively controls the natality of jenny, also effectively improves the natality of buck.What the compound of this invention can make normal reproduction filial generation malely heightens to 20:1 for 1:1 than female.Therefore the present invention has great scientific meaning and social meaning.
accompanying drawing illustrates:
fig. 1the nuclear magnetic resonance map of the end-product of embodiment 1.
Detailed description of the invention
Specific embodiment is described in further detail the present invention below, but the present invention not only limits to following examples.
Preparation embodiment is as follows:
embodiment 1
1) the dendritic macromole polyamide-amine G3(taking S-S as core is purchased), under the catalysis of sodium sulfite (being purchased) 24 hours in dichloromethane solution reduction decomposition be good for half active dendritic macromole G with SH
3;
Be reduced to
2) branched compound L inkerA(is commercially available, also can prepare) at N, adding acetic anhydride under dinethylformamide and trifluoroacetic acid catalysis, to generate LinkerB(also commercially available), then LinkerB and the low drug doxorubicin (being purchased) of dissolubility are under the condition of 7 at PH, normal-temperature reaction reaction coupling in 24 hours generates the compd B with branched structure, and then lyophilizing is for subsequent use;
，
（linker A）
TFA；anhydr；DMF
（linker B）
+
3) compd B of a mole and the compd A of two moles 10 degree chloroform, spend the night in the mutual miscible fluid of petroleum ether low speed 100rpm stirring reaction, is obtained by reacting the dendrimer C containing compound structure not soluble in water;
+
4) by after preparing the washing in aqueous with the compound structure not soluble in water dendrimer C that is core of gained, in vacuum drying oven, lyophilizing 48 hours, obtains final products for subsequent use;
embodiment 2
1) the dendritic macromole polyamide-amine G4(taking S-S as core is purchased), under the catalysis of sodium sulfite (being purchased) 24 hours in dichloromethane solution reduction decomposition be good for half active dendritic macromole G4 with SH;
2) branched compound L inkerA(is commercially available, also can prepare) at N, adding acetic anhydride under dinethylformamide and trifluoroacetic acid catalysis, to generate LinkerB(also commercially available), then LinkerB and the low compound daunorubicin (being purchased) of dissolubility are under the condition of 7.5 at PH, normal-temperature reaction reaction coupling in 20 hours generates the compd B with branched structure, and then lyophilizing is for subsequent use;
3) compd B of a mole and the compd A of two moles spend the night low speed 200rpm stirring reaction in the chloroformic solution of 20 degree, are obtained by reacting the dendrimer C containing compound structure not soluble in water;
4) by after preparing the washing in aqueous with the compound structure not soluble in water dendrimer C that is core of gained, in vacuum drying oven, lyophilizing 24 hours, obtains final products for subsequent use;
effect experimental is as follows:
The lyophilizing sample prepared by embodiment 1-2 and daunorubicin and doxorubicin all weigh identical weight, be configured to the thing medication group of 10mg/100ml, compare group with distilled water with distilled water solution, investigate the compounds of this invention to the regulation and control of sex.
To other experiment of mice fertility control:
Laboratory animal and grouping
Buy and be used for NIH mice in zooperal 7 week age, male and female are normal after separating raises for experiment after 2 weeks, and adapt to the environment of experiment with this, mice freely takes food, drink water, every day changes fresh water, changes bedding and padding 1 time weekly.Foodstuff amount through observation Mus is every every day of 5 g/().By the method for random packet, laboratory animal is divided into 5 groups, is respectively matched group and 4 medication groups, often organize each 40 NIH female mices, be divided into medication group 4 groups: be specially embodiment 1-2 group and daunorubicin group and doxorubicin group.And blank group 1 group.
The foundation of animal model
Fixing mice, the vaginal orifice of all for medication group 4 groups female Mus is all instilled the pharmaceutical aqueous solution of 3 corresponding medicines, concentration is 10mg/100ml, is respectively embodiment 1, embodiment 2, doxorubicin, the aqueous solution of daunorubicin.Matched group distilled water instills.Then immediately by male Mus and female Mus with cage 2 days, wherein male Mus and female Mus ratio are 1:1, namely often organize and all put into 40 male Mus, divide cage after 2 days.Female Mus raises 2 months, normally feeds, and notes collecting and often organizes and newly give birth to mice, so as not to hinder by adult rats.Mice number and sex is added up after February.
Experimental result
Experimental result is in table 1
The sex of the new fertility mice that table 1 is respectively organized and number
| Group | New fertility male mice | New fertility female mice | Fertility total mice order |
| Normal group | 9 | 10 | 19 |
| Embodiment 1 group | 21 | 1 | 22 |
| Embodiment 2 groups | 20 | 1 | 21 |
| Doxorubicin group | 8 | 9 | 17 |
| Daunorubicin group | 8 | 8 | 16 |
Data can clearly be found out by experiment, and embodiment group controls the sex of fertility filial generation effectively, and male female ratio is changed to 20:1 from the 1:1 of normal group.
Claims (10)
1. a kind of new dendritic macromole containing compound structure in the structure be shown below, its feature is the core of compound at dendritic macromole, and periphery is symmetrical dendritic macromole, and its structure is as follows:
。
2. the compound of claim 1, core structure portion wherein in this new dendrimer compound is compound, described Compound I nsoluble represents dissolubility in a kind of water and is less than the compound of 10g, compound namely not soluble in water, containing being slightly soluble in water or being insoluble in the compound of water.
In the structure of the 3. compound of claim 1
Representative take S-S as kernel, and the m of the height cladodification of approximate sphericity is for dendritic macromole, and wherein m is the algebraically of dendritic macromole, and m gets the multiple of integer between 0-50 and 0.5.
4. the compound of claim 1, Linker wherein in structure represents a kind of branch structure compound with three Ge Zhicha branches, a branch is connected with compound chemistry not soluble in water, another two branches and dendritic macromole chemistry is connected, the compound that to be formed with the compound not soluble in water periphery that is core be dendritic macromole.
5. the branched compound of claim 4, this branched compound contains the active group that can react with-SH.
6. the branched compound of claim 5, preferably
，
。
7. the preparation method of compound as claimed in claim 1, is characterized in that:
1) will be with S-S the dendritic macromole G of core
m, wherein m is the algebraically of dendritic macromole, and m gets the multiple of integer between 0-50 and 0.5, G
mbe decomposed under the catalysis of vitamin C, dithiothreitol, DTT or sodium sulfite and be good for half active dendritic macromole G with SH
ma;
2) branched compound L inker and Compound I nsoluble(dissolubility not soluble in water are less than 10g) coupling generates compd B with branched structure;
3) compd A stirred overnight in the solvent of 0-20 degree of the compd B of a times mole and twice mole is reacted, and is obtained by reacting the dendrimer compound C containing compound structure not soluble in water;
4) will the dendrimer compound C lyophilizing 24-96 hour in vacuum drying oven being core with compound structure not soluble in water of gained be prepared, obtain final products for subsequent use;
React described structure as follows
Dendrimer compound Gm:
；
Compd A:
；
Compd B:
Wherein this structure
Belong to the structure in Linker structure;
Compound C:
。
8. the method for claim 7, wherein said chemical step 1-4 selects solvent to be selected from: methyl ether, ether, petroleum ether, benzene, toluene, pyridine, oxolane, trifluoroacetic acid, chloroform, carbon tetrachloride, 3-(2-pyridine dimercapto) propanoic acid N-hydroxy-succinamide ester, tricresyl phosphate (2-chloroethyl) ester, dichloromethane, methanol, ethanol, dichloromethane, dimethyl sulfoxide, N, one or more in dinethylformamide, N, N'-dicyclohexylcarbodiimide.
9. the purposes of the compound of claim 1, the dendrimer compound purposes that should be core with compound structure not soluble in water is the ability of regulation and control fertility sex of children in the non-external fertilization and normal reproduction process of human or animal.
10. the purposes of the compound of claim 9, it is more male and less female that the compound of this invention can make human or animal give birth to after normal fertilization, normal reproduction filial generation male than female be 1:1, be 20:1 after using this compound.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310481091.0A CN104558624A (en) | 2013-10-15 | 2013-10-15 | Preparation and usage of novel dendrimer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310481091.0A CN104558624A (en) | 2013-10-15 | 2013-10-15 | Preparation and usage of novel dendrimer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104558624A true CN104558624A (en) | 2015-04-29 |
Family
ID=53075756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310481091.0A Pending CN104558624A (en) | 2013-10-15 | 2013-10-15 | Preparation and usage of novel dendrimer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104558624A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105085930A (en) * | 2013-11-08 | 2015-11-25 | 韩冰 | Novel dendritic macromolecule and its preparation method and use |
| CN106390135A (en) * | 2015-04-21 | 2017-02-15 | 韩冰 | New efficient gene vector, preparation and applications thereof |
| CN107189075A (en) * | 2017-06-06 | 2017-09-22 | 东北石油大学 | A kind of dendrimer compound and its preparation method and use |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012172283A1 (en) * | 2011-06-17 | 2012-12-20 | University Court Of The University Of St Andrews | Method of labelling a biologically active molecule with 5 - fluoro - 5 - deoxypentose or a 3 - fluoro - 3 - deoxypentose |
| CN103127526A (en) * | 2013-02-27 | 2013-06-05 | 万礼 | Tree-like polymer targeting nanometer drug delivery carrier and its preparation method |
-
2013
- 2013-10-15 CN CN201310481091.0A patent/CN104558624A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012172283A1 (en) * | 2011-06-17 | 2012-12-20 | University Court Of The University Of St Andrews | Method of labelling a biologically active molecule with 5 - fluoro - 5 - deoxypentose or a 3 - fluoro - 3 - deoxypentose |
| CN103127526A (en) * | 2013-02-27 | 2013-06-05 | 万礼 | Tree-like polymer targeting nanometer drug delivery carrier and its preparation method |
Non-Patent Citations (2)
| Title |
|---|
| JENILEE WAY: "Fully automated synthesis of 4-[18F] fluorobenzylamine based on borohydride/NiCl2 reduction", 《NUCLEAR MEDICINE AND BIOLOGY》 * |
| NARIHIRO TODA: "Rapid, Stable, Chemoselective Labeling of Thiols with Julia–Kocien´ ski- like Reagents: A Serum-Stable Alternative to Maleimide-Based Protein Conjugation", 《ANGEWANDTE COMMUNICATIONS》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105085930A (en) * | 2013-11-08 | 2015-11-25 | 韩冰 | Novel dendritic macromolecule and its preparation method and use |
| CN106390135A (en) * | 2015-04-21 | 2017-02-15 | 韩冰 | New efficient gene vector, preparation and applications thereof |
| CN107189075A (en) * | 2017-06-06 | 2017-09-22 | 东北石油大学 | A kind of dendrimer compound and its preparation method and use |
| CN107189075B (en) * | 2017-06-06 | 2018-03-02 | 东北石油大学 | A kind of dendrimer compound and its preparation method and use |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hassanein et al. | Efficiency of GnRH–loaded chitosan nanoparticles for inducing LH secretion and fertile ovulations in protocols for artificial insemination in rabbit does | |
| Zhu et al. | Targeted delivery of mannosylated nanoparticles improve prophylactic efficacy of immersion vaccine against fish viral disease | |
| Wu et al. | pH-responsive hyaluronic acid-based mixed micelles for the hepatoma-targeting delivery of doxorubicin | |
| CN104558624A (en) | Preparation and usage of novel dendrimer | |
| Meschaninova et al. | Novel convenient approach to the solid-phase synthesis of oligonucleotide conjugates | |
| Zhou et al. | Solid lipid nanoparticles for duodenum targeted oral delivery of tilmicosin | |
| CN111053911A (en) | Reduction response type cross-linking agent and preparation and application of cross-linked hydroxyl drug molecule thereof | |
| Jiang et al. | Nanocarrier-loaded imidaclothiz promotes plant uptake and decreases pesticide residue | |
| Zhang et al. | Affibody modified G-quadruplex DNA micelles incorporating polymeric 5-Fluorodeoxyuridine for targeted delivery of curcumin to enhance synergetic therapy of HER2 positive gastric cancer | |
| Yu et al. | A novel star like eight-arm polyethylene glycol-deferoxamine conjugate for iron overload therapy | |
| CN104558625A (en) | Novel dendrimer as well as preparation and application thereof | |
| CN104558620A (en) | Preparation and usage of novel dendrimer | |
| CN104558626A (en) | Preparation and usage of novel dendrimer | |
| Chen et al. | Co-delivery of dihydroartemisinin and indocyanine green by metal-organic framework-based vehicles for combination treatment of hepatic carcinoma | |
| Logigan et al. | Chitosan grafted poly (ethylene glycol) methyl ether acrylate particulate hydrogels for drug delivery applications | |
| CN104558627A (en) | Novel dendrimer as well as preparation and application thereof | |
| CN104546819A (en) | Use of dicaffeoylquinic acid in treatment of systemic autoimmune disease | |
| Wang et al. | Easy synthesis and characterization of novel carbon dots using the one-pot green method for cancer therapy | |
| Pau et al. | Reproductive performance following transcervical insemination with frozen thawed semen in ewes submitted to surgical incision of cervical folds (SICF): Comparison with Laparoscopic Artificial Insemination | |
| CN105001296B (en) | A kind of nitric oxide donator type dexamethasone and preparation method and purposes | |
| Brucks et al. | Influence of substituent chain branching on the transfection efficacy of cyclopropenium-based polymers | |
| Mooranian et al. | Polyelectrolytes formulated with primary unconjugated bile acid optimised pharmacology of bio-engineered implant | |
| Abdeen et al. | Integrating biomaterials and genome editing approaches to advance biomedical science | |
| CN105085930A (en) | Novel dendritic macromolecule and its preparation method and use | |
| CN105085931A (en) | Novel dendritic macromolecule and its preparation method and use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150429 |